CordovaCann (LVRLF) Shares Outstanding (Weighted Average) (2009 - 2025)

CordovaCann (LVRLF) recorded quarterly Shares Outstanding (Weighted Average) of $22.1 million in Q2 2025, down 0.94% quarter-over-quarter from $22.3 million in Q2 2024, and down 0.94% on a YoY basis from $22.3 million in Q2 2024.

CordovaCann (LVRLF) Shares Outstanding (Weighted Average) (2009 - 2025) Analysis & Trends

CordovaCann's Shares Outstanding (Weighted Average) history runs 17 years deep, the most recent figure standing at $22.1 million for Q2 2025.

  • In Q2 2025, Shares Outstanding (Weighted Average) fell 0.94% year-over-year to $22.1 million; the TTM figure through Jun 2025 stood at $22.1 million (down 0.94% YoY), while the FY2025 annual figure was $21.9 million, down 2.55% from the prior year.
  • Shares Outstanding (Weighted Average) was $22.1 million for Q2 2025 at CordovaCann, down from $22.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $23.9 million in Q2 2022 to a low of $21.3 million in Q2 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $22.4 million across 5 years, with a median of $22.3 million in 2024.
  • The sharpest annual moves came in 2021 and 2023: Shares Outstanding (Weighted Average) soared 49.73% in 2021, then dropped 5.09% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $21.3 million in 2021, then increased by 12.38% to $23.9 million in 2022, then slipped by 5.09% to $22.7 million in 2023, then dropped by 1.79% to $22.3 million in 2024, then dropped by 0.94% to $22.1 million in 2025.
  • The last three Shares Outstanding (Weighted Average) figures came in at $22.1 million (Q2 2025), $22.3 million (Q2 2024), and $22.7 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.16 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 166.20 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 64.74 Mn
10 CordovaCann - - - 22.07 Mn

Historic Data

Download Data
DateValue
Jun 30, 2025 22.07 Mn
Jun 30, 2024 22.28 Mn
Jun 30, 2023 22.69 Mn
Jun 30, 2022 23.90 Mn
Jun 30, 2021 21.27 Mn
Jun 30, 2020 14.21 Mn
Mar 31, 2020 11.12 Mn
Dec 31, 2019 11.09 Mn
Sep 30, 2019 11.09 Mn
Jun 30, 2019 30.48 Mn
Mar 31, 2019 10.89 Mn
Dec 31, 2018 10.97 Mn
Sep 30, 2018 11.08 Mn
Jun 30, 2018 31.03 Mn
Mar 31, 2018 109.19
Dec 31, 2017 7.24 Mn
Sep 30, 2017 0.80
Jun 30, 2017 17.49 Mn
Mar 31, 2017 2.27
Dec 31, 2016 1.50